July 9 (Reuters) - Eli Lilly and Co LLY.N:
ELI LILLY: FDA APPROVES UPDATED LABEL FOR KISUNLA WITH NEW DOSING IN EARLY SYMPTOMATIC ALZHEIMER'S DISEASE
ELI LILLY: NEWLY RECOMMENDED DOSING SCHEDULE SIGNIFICANT LOWERED ARIA-E RATES VERSUS ORIGINAL SCHEDULE
Source text: [ID:]